Randomized clinical trials presented at the world congress of endourology: How is the quality of reporting?

Riccardo Autorino, Claudio Borges, Michael A. White, Fatih Altunrende, Sisto Perdoná, Georges Pascal Haber, Marco De Sio, Rakesh Khanna, Robert J. Stein, Jihad H. Kaouk

Research output: Contribution to journalArticle

Abstract

Purpose: To assess the quality of reporting of randomized conrolled trials (RCTs) presented in abstract form at the annual World Congress of Endourology (WCE) and evaluate their course of subsequent publication. Materials and Methods: All RCTs presented in abstract form at the 2004, 2005, and 2006 WCE annual meetings were identified for review. Quality of reporting was assessed by applying a standardized 14-item evaluation tool based on the Consolidated Standards for the Reporting of Trials (CONSORT) statement. The subsequent publication rate for the corresponding studies by scanning Medline was also evaluated. Appropriate statistical analysis was performed. Results: A total of 94 RCTs (3.5% of 2669) were identified for review: 21 in 2004, 36 in 2005, and 37 in 2006. Overall, 45 (47.3% of the total) were subsequently published as a full length indexed manuscript with a mean time to publication of 16.4±13.2 months. Approximately 61 (60%) identified the study design as RCT in the abstract title. None reported the method of randomization. In studies that reported blinding (seven, 11% of 62), five were double blinded and two single blinded. Adverse events were reported in 38% of cases. Only 10% of the abstracts complied fully with more than 10 items according to our CONSORT-based checklist, whereas the majority of them failed to comply with most of the CONSORT requirements. Conclusions: Although representing a small portion of the overall number of abstracts, there has been a steady increase of presentation of RCTs at the WCE over the assessed 3-year period. Most of the time they are recognized as RCTs in the abstract title. When applying the CONSORT criteria, necessary information to assess their methodologic quality is incomplete in some cases.

Original languageEnglish
Pages (from-to)2067-2073
Number of pages7
JournalJournal of Endourology
Volume24
Issue number12
DOIs
Publication statusPublished - Dec 1 2010

Fingerprint

Randomized Controlled Trials
Publications
Manuscripts
Random Allocation
Checklist

ASJC Scopus subject areas

  • Urology

Cite this

Randomized clinical trials presented at the world congress of endourology : How is the quality of reporting? / Autorino, Riccardo; Borges, Claudio; White, Michael A.; Altunrende, Fatih; Perdoná, Sisto; Haber, Georges Pascal; De Sio, Marco; Khanna, Rakesh; Stein, Robert J.; Kaouk, Jihad H.

In: Journal of Endourology, Vol. 24, No. 12, 01.12.2010, p. 2067-2073.

Research output: Contribution to journalArticle

Autorino, R, Borges, C, White, MA, Altunrende, F, Perdoná, S, Haber, GP, De Sio, M, Khanna, R, Stein, RJ & Kaouk, JH 2010, 'Randomized clinical trials presented at the world congress of endourology: How is the quality of reporting?', Journal of Endourology, vol. 24, no. 12, pp. 2067-2073. https://doi.org/10.1089/end.2009.0541
Autorino, Riccardo ; Borges, Claudio ; White, Michael A. ; Altunrende, Fatih ; Perdoná, Sisto ; Haber, Georges Pascal ; De Sio, Marco ; Khanna, Rakesh ; Stein, Robert J. ; Kaouk, Jihad H. / Randomized clinical trials presented at the world congress of endourology : How is the quality of reporting?. In: Journal of Endourology. 2010 ; Vol. 24, No. 12. pp. 2067-2073.
@article{5ab2f26d505343ecb05869e08dbf80ca,
title = "Randomized clinical trials presented at the world congress of endourology: How is the quality of reporting?",
abstract = "Purpose: To assess the quality of reporting of randomized conrolled trials (RCTs) presented in abstract form at the annual World Congress of Endourology (WCE) and evaluate their course of subsequent publication. Materials and Methods: All RCTs presented in abstract form at the 2004, 2005, and 2006 WCE annual meetings were identified for review. Quality of reporting was assessed by applying a standardized 14-item evaluation tool based on the Consolidated Standards for the Reporting of Trials (CONSORT) statement. The subsequent publication rate for the corresponding studies by scanning Medline was also evaluated. Appropriate statistical analysis was performed. Results: A total of 94 RCTs (3.5{\%} of 2669) were identified for review: 21 in 2004, 36 in 2005, and 37 in 2006. Overall, 45 (47.3{\%} of the total) were subsequently published as a full length indexed manuscript with a mean time to publication of 16.4±13.2 months. Approximately 61 (60{\%}) identified the study design as RCT in the abstract title. None reported the method of randomization. In studies that reported blinding (seven, 11{\%} of 62), five were double blinded and two single blinded. Adverse events were reported in 38{\%} of cases. Only 10{\%} of the abstracts complied fully with more than 10 items according to our CONSORT-based checklist, whereas the majority of them failed to comply with most of the CONSORT requirements. Conclusions: Although representing a small portion of the overall number of abstracts, there has been a steady increase of presentation of RCTs at the WCE over the assessed 3-year period. Most of the time they are recognized as RCTs in the abstract title. When applying the CONSORT criteria, necessary information to assess their methodologic quality is incomplete in some cases.",
author = "Riccardo Autorino and Claudio Borges and White, {Michael A.} and Fatih Altunrende and Sisto Perdon{\'a} and Haber, {Georges Pascal} and {De Sio}, Marco and Rakesh Khanna and Stein, {Robert J.} and Kaouk, {Jihad H.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1089/end.2009.0541",
language = "English",
volume = "24",
pages = "2067--2073",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Randomized clinical trials presented at the world congress of endourology

T2 - How is the quality of reporting?

AU - Autorino, Riccardo

AU - Borges, Claudio

AU - White, Michael A.

AU - Altunrende, Fatih

AU - Perdoná, Sisto

AU - Haber, Georges Pascal

AU - De Sio, Marco

AU - Khanna, Rakesh

AU - Stein, Robert J.

AU - Kaouk, Jihad H.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Purpose: To assess the quality of reporting of randomized conrolled trials (RCTs) presented in abstract form at the annual World Congress of Endourology (WCE) and evaluate their course of subsequent publication. Materials and Methods: All RCTs presented in abstract form at the 2004, 2005, and 2006 WCE annual meetings were identified for review. Quality of reporting was assessed by applying a standardized 14-item evaluation tool based on the Consolidated Standards for the Reporting of Trials (CONSORT) statement. The subsequent publication rate for the corresponding studies by scanning Medline was also evaluated. Appropriate statistical analysis was performed. Results: A total of 94 RCTs (3.5% of 2669) were identified for review: 21 in 2004, 36 in 2005, and 37 in 2006. Overall, 45 (47.3% of the total) were subsequently published as a full length indexed manuscript with a mean time to publication of 16.4±13.2 months. Approximately 61 (60%) identified the study design as RCT in the abstract title. None reported the method of randomization. In studies that reported blinding (seven, 11% of 62), five were double blinded and two single blinded. Adverse events were reported in 38% of cases. Only 10% of the abstracts complied fully with more than 10 items according to our CONSORT-based checklist, whereas the majority of them failed to comply with most of the CONSORT requirements. Conclusions: Although representing a small portion of the overall number of abstracts, there has been a steady increase of presentation of RCTs at the WCE over the assessed 3-year period. Most of the time they are recognized as RCTs in the abstract title. When applying the CONSORT criteria, necessary information to assess their methodologic quality is incomplete in some cases.

AB - Purpose: To assess the quality of reporting of randomized conrolled trials (RCTs) presented in abstract form at the annual World Congress of Endourology (WCE) and evaluate their course of subsequent publication. Materials and Methods: All RCTs presented in abstract form at the 2004, 2005, and 2006 WCE annual meetings were identified for review. Quality of reporting was assessed by applying a standardized 14-item evaluation tool based on the Consolidated Standards for the Reporting of Trials (CONSORT) statement. The subsequent publication rate for the corresponding studies by scanning Medline was also evaluated. Appropriate statistical analysis was performed. Results: A total of 94 RCTs (3.5% of 2669) were identified for review: 21 in 2004, 36 in 2005, and 37 in 2006. Overall, 45 (47.3% of the total) were subsequently published as a full length indexed manuscript with a mean time to publication of 16.4±13.2 months. Approximately 61 (60%) identified the study design as RCT in the abstract title. None reported the method of randomization. In studies that reported blinding (seven, 11% of 62), five were double blinded and two single blinded. Adverse events were reported in 38% of cases. Only 10% of the abstracts complied fully with more than 10 items according to our CONSORT-based checklist, whereas the majority of them failed to comply with most of the CONSORT requirements. Conclusions: Although representing a small portion of the overall number of abstracts, there has been a steady increase of presentation of RCTs at the WCE over the assessed 3-year period. Most of the time they are recognized as RCTs in the abstract title. When applying the CONSORT criteria, necessary information to assess their methodologic quality is incomplete in some cases.

UR - http://www.scopus.com/inward/record.url?scp=78650296834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650296834&partnerID=8YFLogxK

U2 - 10.1089/end.2009.0541

DO - 10.1089/end.2009.0541

M3 - Article

C2 - 20874488

AN - SCOPUS:78650296834

VL - 24

SP - 2067

EP - 2073

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 12

ER -